Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001673232-25-000018

PRESIDENT AND COO sold 22,500 shares at $502.79 ($11,312,710)

  • PRESIDENT AND COO acquired 14,625 shares (option exercise)
  • PRESIDENT AND COO acquired 7,875 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENKOWITZ MICHAEL · PRESIDENT AND COO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-29 Exercise or conversion : show line 1 in the form 10b5-1 −14,625 $117.76 $1,722,240 14,625 I
2025-12-29 Sale : show line 2 in the form 10b5-1 −14,625 $502.79 $7,353,261 0 I
2025-12-29 Exercise or conversion : show line 3 in the form 10b5-1 +7,875 $146.03 $1,149,986 7,875 I
2025-12-29 Sale : show line 4 in the form 10b5-1 −7,875 $502.79 $3,959,448 0 I
Open-market sales · 22,500 sh · avg $502.79 · $11,312,710

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-12-29 Exercise or conversion : show line 5 in the form 10b5-1 Stock Options −14,625 111,750 I
2025-12-29 Exercise or conversion : show line 6 in the form 10b5-1 Stock Options −7,875 60,190 I
Loading xslF345X05/primarydocument.xml…